SPDR S&P Biotech ETF $XBI Shares Purchased by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 353.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,391 shares of the exchange traded fund’s stock after acquiring an additional 16,673 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,608,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in XBI. AQR Capital Management LLC increased its stake in SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after acquiring an additional 2,167 shares during the last quarter. Marshall Wace LLP increased its stake in SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after acquiring an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company acquired a new stake in SPDR S&P Biotech ETF during the second quarter worth $260,000. Ameriprise Financial Inc. increased its stake in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares during the last quarter. Finally, EP Wealth Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after acquiring an additional 193 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.7%

XBI stock opened at $130.42 on Friday. The stock has a market cap of $8.32 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The business has a fifty day moving average of $127.98 and a two-hundred day moving average of $122.74. SPDR S&P Biotech ETF has a 52-week low of $75.68 and a 52-week high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.